Cargando…
Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts
OBJECTIVE: Malignant peripheral nerve sheath tumors (MPNST) are aggressive sarcomas characterized by high recurrence rates and early metastases. These tumors arise more frequently within neurofibromatosis type 1 (NF1) and present with resistance during standard chemotherapy leading to increased mort...
Autores principales: | Fischer-Huchzermeyer, Susan, Chikobava, Levan, Stahn, Verena, Zangarini, Monique, Berry, Philip, Veal, Gareth J., Senner, Volker, Mautner, Victor F., Harder, Anja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064132/ https://www.ncbi.nlm.nih.gov/pubmed/30055648 http://dx.doi.org/10.1186/s13104-018-3630-0 |
Ejemplares similares
-
MEK inhibitors enhance therapeutic response towards ATRA in NF1 associated malignant peripheral nerve sheath tumors (MPNST) in-vitro
por: Fischer-Huchzermeyer, Susan, et al.
Publicado: (2017) -
Inhibition of glioblastoma dispersal by the MEK inhibitor PD0325901
por: Shannon, Stephen, et al.
Publicado: (2017) -
Malignant transformation of plexiform neurofibroma to MPNST while on MEK inhibitor
por: Fasih, Samir, et al.
Publicado: (2021) -
MEK inhibitor PD0325901 and vitamin C synergistically induce hypomethylation of mouse embryonic stem cells
por: Li, Cuiping, et al.
Publicado: (2016) -
Development and validation of LC–MS/MS with in-source collision-induced dissociation for the quantification of pegcantratinib in human skin tumors
por: Zangarini, Monique, et al.
Publicado: (2017)